Learn More
Medchemexpress LLC Pralsetinib | 2097132-94-8 | 533.60 | 25 MG

Supplier: Medchemexpress LLC 25MGHY112301
Pralsetinib (BLU-667) is a highly potent, selective RET inhibitor. It inhibits WT RET, RET mutants V804L, V804M, M918T and CCDC6-RET fusion with IC50s of 0.4, 0.3, 0.4, 0.4, and 0.4 nM, respectively. This compound demonstrates potent activity against common oncogenic RET alterations, including RET M918T and the CCDC6-RET fusion, suppressing RET pathway signaling in various cell lines.
- Highly potent and selective RET inhibitor.
- Inhibits various RET mutants and fusions with high efficacy.
- Effective against oncogenic RET alterations.
- Suppresses RET pathway signaling.
- Powder stable at -20°C for 3 years, 4°C for 2 years.
- In solvent stable at -80°C for 2 years, -20°C for 1 year.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.